Salvatore Sotgia

Dr. Salvatore Sotgia

University of Sassari, Department of Biomedical Sciences
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2018 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
Panagiotis PaliogiannisPanagiotis Paliogiannis
Panagiotis Paliogiannis
Alessandro FoisAlessandro Fois
Alessandro Fois
SSSalvatore Sotgia
Salvatore Sotgia
Arduino MangoniArduino Mangoni
Arduino Mangoni
EZElisabetta Zinellu
Elisabetta Zinellu
AZAngelo Zinellu
Angelo Zinellu
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a common cause of hospitalisation and death among COPD patients. Several biochemical markers have been studied as outcome predictors in COPD; however, their measurement often requires significant time and resources. Relatively simple biomarkers of inflammation calculated from routine complete blood count tests, such as the neutrophil to lymphocyte ratio (NLR), might also predict COPD progression and outcomes. This review discusses the available evidence from studies investigating the associations between the NLR, COPD exacerbations and death in this patient group.

27 March 2018 in Respiratory Research
Verified
Journal Article
Open access
PDF file
Alessandro FoisAlessandro Fois
Alessandro Fois
Panagiotis PaliogiannisPanagiotis Paliogiannis
Panagiotis Paliogiannis
SSSalvatore Sotgia
Salvatore Sotgia
Arduino MangoniArduino Mangoni
Arduino Mangoni
EZElisabetta Zinellu
Elisabetta Zinellu
AZAngelo Zinellu
Angelo Zinellu
Idiopathic pulmonary fibrosis (IPF), a fatal lung disease of unknown origin, is characterized by chronic and progressive fibrosing interstitial pneumonia which progressively impairs lung function. Oxidative stress is one of the main pathogenic pathways in IPF. The aim of this systematic review was to describe the type of markers of oxidative stress identified in different biological specimens and the effects of antioxidant therapies in patients with IPF. We conducted a systematic search of publications listed in electronic databases (Pubmed, Web of Science, Scopus and Google Scholar) from inception to October 2017. Two investigators independently reviewed all identified articles to determine eligibility. After a substantial proportion of the initially identified articles (n = 554) was excluded because they were duplicates, abstracts, irrelevant, or did not meet the selection criteria, we identified 30 studies. In each study, we critically appraised the type, site (systemic vs. local, e.g. breath, sputum, expired breath condensate, epithelial lining fluid, bronchoalveolar lavage, and lung tissue specimens), and method used for measuring the identified oxidative stress biomarkers. Furthermore, the current knowledge on antioxidant therapies in IPF was summarized. A number of markers of oxidative stress, with individual advantages and limitations, have been described in patients with IPF. Nevertheless, trials of antioxidant treatments have been unable to demonstrate consistent benefits, barring recent pharmacogenomics data suggesting different results in specific genotype subgroups of patients with IPF.

1 April 2015 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
APAnna Maria Posadino
Anna Maria Posadino
ACAnnalisa Cossu
Annalisa Cossu
RGRoberta Giordo
Roberta Giordo
AZAngelo Zinellu
Angelo Zinellu
SSSalvatore Sotgia
Salvatore Sotgia
Gianfranco PintusGianfranco Pintus
Gianfranco Pintus

24 April 2018 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
Panagiotis PaliogiannisPanagiotis Paliogiannis
Panagiotis Paliogiannis
GGGiorgio C. Ginesu
Giorgio C. Ginesu
CTCinzia Tanda
Cinzia Tanda
Claudio FeoClaudio Feo
Claudio Feo
Alessandro FancelluAlessandro Fancellu
Alessandro Fancellu
AXAndreas Xidas
Andreas Xidas

1 March 2004 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
Ciriaco CarruCiriaco Carru
Ciriaco Carru
LDLuca Deiana
Luca Deiana
SSSalvatore Sotgia
Salvatore Sotgia
Giovanni Mario PesGiovanni Mario Pes
Giovanni Mario Pes
AZAngelo Zinellu
Angelo Zinellu

20 June 2018 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
Panagiotis PaliogiannisPanagiotis Paliogiannis
Panagiotis Paliogiannis
AFAlessandro G Fois
Alessandro G Fois
SSSalvatore Sotgia
Salvatore Sotgia
Arduino MangoniArduino Mangoni
Arduino Mangoni
EZElisabetta Zinellu
Elisabetta Zinellu
AZAngelo Zinellu
Angelo Zinellu
Introduction: The main white blood cell populations, neutrophils and lymphocytes, are involved in the pathophysiology of chronic obstructive pulmonary disease (COPD). We conducted a systematic review and meta‐analysis of studies investigating the relationship between the neutrophil to lymphocyte ratio (NLR, a marker of subclinical inflammation), presence of COPD, and its exacerbations.Methods: A comprehensive literature search was conducted in Pubmed, Web of Science and Scopus databases; two investigators independently reviewed suitable studies.Results: Nine studies, from 247 initially identified, were included in the meta‐analysis. Seven studies, in 775 COPD patients with stable disease and 496 healthy controls, showed a significant increase in NLR values in stable COPD (standardised mean difference, SMD, 0.773, 95% CI 0.410‐1.136; P < 0.001). Furthermore, in six studies in 527 COPD patients with acute exacerbation and 620 COPD patients with stable disease, NLR values were significantly higher in patients with exacerbations (random effects SMD 0.850, 95% CI 0.549‐1.151; P < 0.001).Conclusions: Our meta‐analysis showed that NLR values are significantly higher in stable COPD patients when compared to healthy individuals, although the magnitude of the difference is reduced after trim and fill adjustment, and in patients with COPD exacerbations when compared to patients with stable disease. Further studies, in larger cohorts, are needed to confirm whether the NLR is a useful tool in discriminating between COPD patients with stable disease, those with acute exacerbations, and subjects without the disease.